Close Menu

NEW YORK – The US Attorney's Office for the Western District of Louisiana announced Tuesday that a federal grand jury indicted the owner of Specialty Drug Testing, a clinical and anatomical pathology laboratory, for paying bribes and kickbacks that led to improper billings to Medicare of approximately $117 million.

The indictment alleged that Medicare paid Specialty approximately $28.7 million or more as a result of the false and fraudulent claims.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.